Anna Paola Cellai Selected Research

Plasminogen Activators (Plasminogen Activator)

3/2021

Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Paola Cellai Research Topics

Disease

2	Cardiovascular Diseases (Cardiovascular Disease) 05/2016 - 12/2003
2	Pulmonary Embolism 07/2014 - 03/2013
1	Ascites 03/2021
1	Pregnancy Complications 05/2016
1	Pulmonary Hypertension 07/2014
1	Overweight 12/2012
1	Atherosclerosis 11/2007
1	Peripheral Arterial Disease 11/2007
1	Embolism (Embolus) 10/2005
1	Stroke (Strokes) 10/2005
1	Atrial Fibrillation 10/2005
1	Hypertension (High Blood Pressure) 10/2005
1	Venous Thromboembolism 12/2003
1	Ovarian Hyperstimulation Syndrome 04/2003
1	Thrombophilia 04/2003

Drug/Important Bio-Agent (IBA)

2	Lipoprotein(a)IBA 05/2016 - 12/2003
2	FibrinIBA 07/2014 - 03/2013
1	Matrix Metalloproteinases (MMPs)IBA 03/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2021
1	fibrin fragment D (D-dimer)IBA 03/2021
1	PlasminogenIBA 03/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2021
1	Metalloproteases (Metalloproteinases)IBA 03/2021
1	GelatinasesIBA 03/2021
1	Fibrinolysin FDA Link 07/2014
1	Plasminogen Activator Inhibitor 1IBA 12/2012
1	plasma protein Z (protein Z)IBA 11/2007
1	Warfarin (Coumadin)FDA LinkGeneric 10/2005
1	AnticoagulantsIBA 10/2005
1	HomocysteineIBA 10/2005
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 04/2003
1	Thromboplastin (Tissue Factor)IBA 04/2003

Therapy/Procedure

1	Vascular Surgical Procedures 11/2007
1	Therapeutics 10/2005